113 related articles for article (PubMed ID: 23761583)
1. Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study.
Mukhtar TK; Yeates DR; Goldacre MJ
J R Soc Med; 2013 Jun; 106(6):234-42. PubMed ID: 23761583
[TBL] [Abstract][Full Text] [Related]
2. Radiation risk of breast screening in England with digital mammography.
Warren LM; Dance DR; Young KC
Br J Radiol; 2016 Nov; 89(1067):20150897. PubMed ID: 27585843
[TBL] [Abstract][Full Text] [Related]
3. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.
Duffy SW; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith RA; Evans A; Blyuss O; Johns L; Ellis IO; Myles J; Sasieni PD; Moss SM
Lancet Oncol; 2020 Sep; 21(9):1165-1172. PubMed ID: 32800099
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program.
Hofvind S; Ursin G; Tretli S; Sebuødegård S; Møller B
Cancer; 2013 Sep; 119(17):3106-12. PubMed ID: 23720226
[TBL] [Abstract][Full Text] [Related]
5. Trends in breast cancer screening rates among Korean women: results from the Korean National Cancer Screening Survey, 2005-2020.
Song SY; Lee YY; Shin HY; Park B; Suh M; Choi KS; Jun JK
Epidemiol Health; 2022; 44():e2022111. PubMed ID: 36470263
[TBL] [Abstract][Full Text] [Related]
6. Increasingly strong reduction in breast cancer mortality due to screening.
van Schoor G; Moss SM; Otten JD; Donders R; Paap E; den Heeten GJ; Holland R; Broeders MJ; Verbeek AL
Br J Cancer; 2011 Mar; 104(6):910-4. PubMed ID: 21343930
[TBL] [Abstract][Full Text] [Related]
7. Changes in the availability of screening mammography, 2000-2010.
Elkin EB; Atoria CL; Leoce N; Bach PB; Schrag D
Cancer; 2013 Nov; 119(21):3847-53. PubMed ID: 23943323
[TBL] [Abstract][Full Text] [Related]
8. Non-normal Screening Mammography Results, Lumpectomies, and Breast Cancer Reported by California Women, 2001-2009.
Irvin VL; Breen N; Meissner HI; Liu B; Kaplan RM
Womens Health Issues; 2015; 25(4):331-40. PubMed ID: 26070253
[TBL] [Abstract][Full Text] [Related]
9. Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976-2009.
Parvinen I; Heinävaara S; Anttila A; Helenius H; Klemi P; Pylkkänen L
Br J Cancer; 2015 Mar; 112(5):918-24. PubMed ID: 25688742
[TBL] [Abstract][Full Text] [Related]
10. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database.
Autier P; Boniol M; La Vecchia C; Vatten L; Gavin A; Héry C; Heanue M
BMJ; 2010 Aug; 341():c3620. PubMed ID: 20702548
[TBL] [Abstract][Full Text] [Related]
11. Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based study.
Baeyens-Fernández JA; Molina-Portillo E; Pollán M; Rodríguez-Barranco M; Del Moral R; Arribas-Mir L; Sánchez-Cantalejo Ramírez E; Sánchez MJ
BMC Cancer; 2018 Aug; 18(1):781. PubMed ID: 30068302
[TBL] [Abstract][Full Text] [Related]
12. Impacts of the Finnish service screening programme on breast cancer rates.
Anttila A; Sarkeala T; Hakulinen T; Heinävaara S
BMC Public Health; 2008 Jan; 8():38. PubMed ID: 18226204
[TBL] [Abstract][Full Text] [Related]
13. Harms and benefits of mammographic screening for breast cancer in Brazil.
Migowski A; Nadanovsky P; Manso de Mello Vianna C
PLoS One; 2024; 19(1):e0297048. PubMed ID: 38271392
[TBL] [Abstract][Full Text] [Related]
14. Impact of changes to invite methodology on equality of access to the National Breast Screening Programme in the South of England.
Westrop SJ; Thomas A; Williams A; Johnson F; Liao H; Edlin K; Burgess K; Kearins O; Maclean R
J Med Screen; 2024 Jun; 31(2):115-118. PubMed ID: 38105465
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of Breast Cancer Mortality in Kazakhstan, trends and Geographic Distribution.
Igissinov N; Toguzbayeva A; Khamidullina Z; Telmanova Z; Bilyalova Z; Kudaibergenova I; Muratbekova S; Igissinova G; Rustemova K; Kulmirzayeva D; Syzdykov N; Taszhanov R; Turebayev D; Orazova G; Kassenova D; Detochkina V; Baibosynov D; Kuandykov Y
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3361-3371. PubMed ID: 37898839
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer screening: are we seeing the benefit?
Puliti D; Zappa M
BMC Med; 2012 Sep; 10():106. PubMed ID: 22995098
[TBL] [Abstract][Full Text] [Related]
17. Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland.
Bennett RL; Sellars SJ; Moss SM
Br J Cancer; 2011 Feb; 104(4):571-7. PubMed ID: 21285989
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction.
Puliti D; Miccinesi G; Collina N; De Lisi V; Federico M; Ferretti S; Finarelli AC; Foca F; Mangone L; Naldoni C; Petrella M; Ponti A; Segnan N; Sigona A; Zarcone M; Zorzi M; Zappa M; Paci E;
Br J Cancer; 2008 Aug; 99(3):423-7. PubMed ID: 18665188
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer mortality and associated factors in São Paulo State, Brazil: an ecological analysis.
Diniz CSG; Pellini ACG; Ribeiro AG; Tedardi MV; Miranda MJ; Touso MM; Baquero OS; Santos PCD; Chiaravalloti-Neto F
BMJ Open; 2017 Aug; 7(8):e016395. PubMed ID: 28838894
[TBL] [Abstract][Full Text] [Related]
20. Assessing trends of breast cancer and carcinoma in situ to monitor screening policies in developing settings.
Brito ÉAC; Lima MS; Siqueira HFF; Marques AD; Moura AR; Hora EC; Lima CA; Santos MO; de Souza MC; da Silva AM; Brito HLF; Cipolotti R
Sci Rep; 2019 Oct; 9(1):14144. PubMed ID: 31578436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
